Sarepta Therapeutics Updates Of BLA For Sarepta's Duchenne Muscular Dystrophy Drug Candidate

Quest Diagnostics Says FDA Grants Breakthrough Designation For Adeno-associated Virus Test

Quest Diagnostics (DGX), a diagnostic information services provider, announced Wednesday that its AAVrh74 ELISA assay (CDx) has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).

RTTNews | 603日前

FDA OKs Elevidys As First Gene Therapy To Treat Duchenne Muscular Dystrophy

Sarepta Therapeutics, Inc. announced Friday that the U.S. Food and Drug Administration or FDA has accelerated approval of ELEVIDYS (delandistrogene moxeparvovec-rokl) for the treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene.

RTTNews | 671日前

Sarepta Submits BLA For SRP-9001 To Treat Ambulant Patients With Duchenne Muscular Dystrophy

Genetic medicine maker Sarepta Therapeutics, Inc. (SRPT) announced Thursday that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the accelerated approval of SRP-9001 (delandistrogene moxeparvovec) to treat ambulant patients with Duchenne muscular dystrophy.

RTTNews | 938日前

Sarepta Therapeutics Says FDA Lifts Clinical Hold On SRP-5051 To Treat Duchenne Muscular Dystrophy

Genetic medicine maker Sarepta Therapeutics, Inc. (SRPT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on SRP-5051 (vesleteplirsen), the Company's investigational, next-generation peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) to treat patients with Duchenne muscular dystrophy who are amenable to exon 51 skipping.

RTTNews | 961日前

Sensex, Nifty Edge Higher In Cautious Trade

Indian shares traded slightly higher on Friday, mirroring firm cues from global markets as traders hoped for favorable outcome from ongoing trade negotiations and comments by a Federal Reserve official bolstered odds that the central bank will cut interest rates as early as June.

RTTNews | 48分前

Asian Markets Track Wall Street Higher

Asian stock markets are mostly higher on Friday, following the broadly positive from Wall Street overnight, as traders remain optimistic about a favorable outcome from the ongoing tariff negotiations between the U.S. and several partner countries, particularly China, Japan, South Korea and India. Comments from two US Fed officials about cutting interest rates also improved market sentiment.

RTTNews | 1時44分前

Japanese Market Sharply Higher

Extending the gains in the previous two sessions, the Japanese market is sharply higher on Friday, following the broadly positive cues from Wall Street overnight. The Nikkei 225 is surging to stay just below the 35,600 level, with gains across all sectors led by index heavyweights, exporters and technology stocks.

RTTNews | 2時11分前

Sensex, Nifty Seen Higher At Open

Indian shares look set to open higher on Friday after U.S. Treasury Secretary Scott Bessent said the U.S. and South Korea could reach an "agreement of understanding" on trade as soon as next week.

RTTNews | 2時24分前

EURUSD	1.13357	GBPUSD	1.32869	AUDUSD	0.64089
USDJPY	143.636	USDCAD	1.38738	USDCHF	0.83156

Advertisement

Sarepta Therapeutics Updates Of BLA For Sarepta's Duchenne Muscular Dystrophy Drug Candidate